ArticleCancer chemotherapy and pharmacology2026

KAT2B-mediated epigenetic suppression of RAD51C enhances olaparib sensitivity in colorectal cancer.

Xiaoqin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.